Moleculin Biotech(DE:MOL)
€7.580.00 (0.00%)
DE:MOL
Moleculin Biotech earnings date
€7.58
At close:0.00 (0.00%)
Moleculin Biotech (MOL) Q3 2022 Earnings Report
3 Followers
DE:MOL Q3 2022 EPS Results
- Actual EPS
- -EUR 2,014.54
- Consensus EPS
- -EUR 92.89
- Beat/Miss
- Missed by -EUR 1,921.64
- One Year Ago EPS
- -EUR 1,007.27
DE:MOL Q3 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/10/2022
- Time
- After Close
- Conference Call
- Thursday, November 10, 2022
DE:MOL Upcoming Earnings
Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:MOL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | 2.34 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -27.82-25.07 | -219.36 | 88.57% (+194.29) | |
| May 15, 2026 | 2026 (Q1) | -41.78-63.39 | -308.9 | 79.48% (+245.50) | |
| Mar 19, 2026 | 2025 (Q4) | -109.4746.74 | 111.92 | -58.24% (-65.18) | |
| Nov 17, 2025 | 2025 (Q3) | -5.89-15.23 | -63.79 | 76.12% (+48.56) | |
| Aug 13, 2025 | 2025 (Q2) | -192.50-219.36 | -761.05 | 71.18% (+541.69) | |
| May 14, 2025 | 2025 (Q1) | -248.46-308.90 | -904.3 | 65.84% (+595.41) | |
| Mar 24, 2025 | 2024 (Q4) | -574.52111.92 | -2247.33 | 104.98% (+2359.25) | |
| Nov 11, 2024 | 2024 (Q3) | -1092.33-1275.87 | -1275.87 | 0.00% (+0.00) | |
| Aug 14, 2024 | 2024 (Q2) | -1123.66-761.05 | -1343.02 | 43.33% (+581.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
